FDA Determines Regulatory Review Period for GORE TAG THORACIC BRANCH ENDOPROSTHESIS Patent Extension

Summary

The US Food and Drug Administration (FDA) has published a notice determining the regulatory review period for the GORE TAG THORACIC BRANCH ENDOPROSTHESIS medical device, following submissions to the US Patent and Trademark Office (USPTO) for patent extension.